ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $81,820,000 | +1037.3% | 475,420 | +729.3% | 0.05% | +1100.0% |
Q2 2021 | $7,194,000 | -4.8% | 57,327 | +2.9% | 0.00% | -20.0% |
Q1 2021 | $7,553,000 | +1866.9% | 55,699 | +1756.6% | 0.01% | – |
Q4 2020 | $384,000 | -54.2% | 3,000 | -59.7% | 0.00% | -100.0% |
Q3 2020 | $838,000 | -95.4% | 7,446 | -96.1% | 0.00% | -96.0% |
Q2 2020 | $18,268,000 | -16.9% | 191,747 | -21.6% | 0.02% | -49.0% |
Q1 2020 | $21,993,000 | +4820.1% | 244,725 | +2800.3% | 0.05% | +4800.0% |
Q4 2019 | $447,000 | -72.8% | 8,438 | -79.7% | 0.00% | -66.7% |
Q3 2019 | $1,644,000 | -57.3% | 41,612 | -55.6% | 0.00% | -50.0% |
Q2 2019 | $3,849,000 | +41.6% | 93,703 | +60.5% | 0.01% | +50.0% |
Q1 2019 | $2,719,000 | +527.9% | 58,384 | +671.3% | 0.00% | +300.0% |
Q3 2018 | $433,000 | -87.0% | 7,570 | -89.0% | 0.00% | -75.0% |
Q2 2018 | $3,328,000 | -42.5% | 68,600 | -53.7% | 0.00% | -50.0% |
Q1 2018 | $5,789,000 | -56.8% | 148,050 | -58.8% | 0.01% | -60.0% |
Q3 2017 | $13,409,000 | -18.8% | 359,304 | -33.9% | 0.02% | -31.0% |
Q2 2017 | $16,516,000 | +14.5% | 543,478 | -0.3% | 0.03% | +11.5% |
Q1 2017 | $14,422,000 | +2784.4% | 544,850 | +2678.3% | 0.03% | +2500.0% |
Q4 2016 | $500,000 | -93.8% | 19,611 | -91.3% | 0.00% | -92.9% |
Q3 2016 | $8,118,000 | +696.7% | 224,314 | +647.7% | 0.01% | +600.0% |
Q2 2016 | $1,019,000 | +54.4% | 30,000 | +20.0% | 0.00% | 0.0% |
Q1 2016 | $660,000 | -98.1% | 25,000 | -96.4% | 0.00% | -97.2% |
Q4 2015 | $34,238,000 | +824.9% | 702,177 | +372.2% | 0.07% | +928.6% |
Q3 2015 | $3,702,000 | +62.8% | 148,693 | +106.9% | 0.01% | +75.0% |
Q2 2015 | $2,274,000 | +190.4% | 71,865 | +211.8% | 0.00% | +100.0% |
Q2 2014 | $783,000 | – | 23,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |